Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity-Reference-Cited by-同舟云学术

Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity

Published:2023-08 Issue: Volume:256 Page:115449
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ishii Takahiro,Kobayakawa Takuya,Matsuda Kouki,Tsuji Kohei,Ohashi Nami,Nakahata Shingo,Noborio Airi,Yoshimura Kazuhisa,Mitsuya Hiroaki,Maeda Kenji,Tamamura Hirokazu

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference58 articles.

1. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro;Mitsuya;Proc. Natl. Acad. Sci. U.S.A.,1985

2. Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV;Ghosh;Bioorg. Med. Chem.,2007

3. Raltegravir: a new antiretroviral class for salvage therapy;Cahn;Lancet,2007

4. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial;Grinsztejn;Lancet,2007

5. Peptide-derived mid-sized anti-HIV agents;Ohashi,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents;ACS Infectious Diseases;2024-05-21

2. The cell biology of HIV-1 latency and rebound;Retrovirology;2024-04-05

3. HIV Reservoirs and Treatment Strategies toward Curing HIV Infection;International Journal of Molecular Sciences;2024-02-23

4. Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents;Expert Opinion on Drug Discovery;2024-01-23

5. Biological evaluation of a phosphate ester prodrug of 10-methyl-aplog-1, a simplified analog of aplysiatoxin, as a possible latency-reversing agent for HIV reactivation;Bioscience, Biotechnology, and Biochemistry;2023-09-08